This disclosure relates to compositions containing apomylated
jellyfish luminescent
protein and methods for treating neuronal
inflammation. The invention relates to a method of premodulating neurons to reduce neuronal
inflammation in a subject. The method includes the step of administering apomylated
jellyfish luminescent
protein to the subject, wherein the subject's neurons are premodulated to reduce subsequent neuronal
inflammation in the subject.